Trials / Unknown
UnknownNCT02561884
A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olostar Tab Versus Two Co-administered Reference Products Olmesartan Medoxomil and Rosuvastatin Calcium in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the bioequivalence of a Olostar Tab versus two co-administered reference IMPs Olmetec and Crestor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olostar Tab. | |
| DRUG | Co-administration of Olmetec and Crestor |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2015-09-28
- Last updated
- 2015-09-28
Source: ClinicalTrials.gov record NCT02561884. Inclusion in this directory is not an endorsement.